Home |
D-chiro-Inositol (1) Sites:
» News on INS-1
Announcement that Insmed has discontinued its internal development of INS-1, one of its investigational drug candidates for type 2 diabetes and polycystic ovary syndrome (PCOS). http://www.corporate-ir.net/ireye/ir_site.zhtml?ticker=insm&script=410&layout=0&item_id=332626 This category needs an editor
Last Updated: 2007-01-02 16:32:57
The content of this directory is based on the Open Directory and has been modified by GoSearchFor.com |